General Information
Revision date
2020-03-31
Product name
Doxorubicin.HCl
1.2.1 Relevant identified uses
For laboratory research purposes Not for drug or household use
Manufacturer Name
BioVision, Inc
Emergency telephone
OTHER CALLS
Icons in SDS
Company Information
company name
BioVision, Inc
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302, H340, H350, H360
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
Product Name/Chemical Name CAS Number EC-No. MW Chemical Formula Concentration Doxorubicin.HCl 25316-40-9 246-818-3 579.98 C27H29NO11 · HCl 100% Doxorubicin.HCl: Emergency Overview
2.3 Other hazards
Target organ effect, Harmful by ingestion, Irritant, Carcinogen Target Organs: Heart, bone marrow, blood, liver
2.1 Classification of the substance or mixture
Acute toxicity, Oral (Category 4), H302 Germ cell mutagenicity (Category 1B), H340 Carcinogenicity (Category 1B), H350 Reproductive toxicity (Category 1B), H360
Signal word
Danger
Hazard statements
H302 Harmful if swallowed. H350 May cause cancer. H360 May damage fertility or the unborn child.
Precautionary statements
P201 Obtain special instructions before use P202 Do not handle until all safety precautions have been read and understood. P264 Wash skin thoroughly after handling. P270 Do not eat, drink or smoke when using this product. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P301 + P312 + P330 IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P405 Store locked up. P501 Dispose of contents/ container to an approved waste disposal plant.
Health hazards
2 Flammability: 0 2 Fire: 0 Reactivity Hazard: 0
Physical hazards
0
Potential health effects
Inhalation: May be harmful if inhaled. May cause respiratory tract irritation. Skin: Harmful if absorbed through skin. Causes skin irritation. Eyes: Causes eye irritation. Ingestion: Harmful if swallowed.
